DK0705846T3 - Höjmolekylære og lavmolekylære fraktioner af von Willebrand-faktor - Google Patents

Höjmolekylære og lavmolekylære fraktioner af von Willebrand-faktor

Info

Publication number
DK0705846T3
DK0705846T3 DK95115442T DK95115442T DK0705846T3 DK 0705846 T3 DK0705846 T3 DK 0705846T3 DK 95115442 T DK95115442 T DK 95115442T DK 95115442 T DK95115442 T DK 95115442T DK 0705846 T3 DK0705846 T3 DK 0705846T3
Authority
DK
Denmark
Prior art keywords
molecular weight
von willebrand
willebrand factor
vwf
high molecular
Prior art date
Application number
DK95115442T
Other languages
English (en)
Other versions
DK0705846T4 (da
Inventor
Bernhard Dr Fischer
Artur Dr Mitterer
Friedrich Prof Dr Dorner
Original Assignee
Baxter Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=6529892&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK0705846(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Baxter Ag filed Critical Baxter Ag
Application granted granted Critical
Publication of DK0705846T3 publication Critical patent/DK0705846T3/da
Publication of DK0705846T4 publication Critical patent/DK0705846T4/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • C07K14/755—Factors VIII, e.g. factor VIII C (AHF), factor VIII Ag (VWF)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Diabetes (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Polymers With Sulfur, Phosphorus Or Metals In The Main Chain (AREA)
DK95115442T 1994-10-04 1995-09-29 Höjmolekylære og lavmolekylære fraktioner af von Wille-brand-faktor DK0705846T4 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4435392A DE4435392B4 (de) 1994-10-04 1994-10-04 Verfahren zur Trennung von vWF in hochmolekularen vWF und niedermolekularen vWF

Publications (2)

Publication Number Publication Date
DK0705846T3 true DK0705846T3 (da) 2004-09-27
DK0705846T4 DK0705846T4 (da) 2009-01-19

Family

ID=6529892

Family Applications (1)

Application Number Title Priority Date Filing Date
DK95115442T DK0705846T4 (da) 1994-10-04 1995-09-29 Höjmolekylære og lavmolekylære fraktioner af von Wille-brand-faktor

Country Status (8)

Country Link
US (3) US5869617A (da)
EP (1) EP0705846B2 (da)
JP (1) JP3110292B2 (da)
AT (2) ATE267841T1 (da)
CA (1) CA2159702C (da)
DE (2) DE4435392B4 (da)
DK (1) DK0705846T4 (da)
ES (1) ES2221926T5 (da)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6005077A (en) * 1995-11-10 1999-12-21 Immuno Aktiengesellschaft Use of von willebrand factor and pharmaceutical formulation
AT403764B (de) * 1996-03-15 1998-05-25 Immuno Ag Stabiler faktor viii/vwf-komplex
AT403765B (de) * 1996-04-12 1998-05-25 Immuno Ag Verfahren zur herstellung einer präparation enthaltend einen hochgereinigten komplex
AT406373B (de) * 1997-02-27 2000-04-25 Immuno Ag Verfahren zur reinigung von faktor viii/vwf-komplex mittels kationenaustauscherchromatographie
AT405403B (de) * 1997-02-27 1999-08-25 Immuno Ag Reinigung von von willebrand-faktor durch kationenaustauscherchromatographie
AT406867B (de) * 1997-02-27 2000-10-25 Immuno Ag Verfahren zur gewinnung von hochreinem vwf oder faktor viii/vwf-komplex
US6531577B1 (en) 1997-12-15 2003-03-11 Hemasure Denmark A/S von Willebrand factor (vWF)-containing preparation, process for preparing vWF-containing preparations, and use of such preparations
FR2772381B1 (fr) 1997-12-15 2001-06-08 Lab Francais Du Fractionnement Procede de preparation par filtration d'une solution de facteur viii securisee viralement
EP1148063A1 (de) * 2000-04-18 2001-10-24 Octapharma AG Haemostatisch aktives vWF enthaltendes Präparat und Verfahren zu seiner Herstellung
DE10246125A1 (de) 2002-10-01 2004-04-15 Aventis Behring Gmbh Konzentrat eines Faktor VIII:C-haltigen von-Willebrand-Faktors und das dazu gehörige Verfahren
EP1593388A1 (en) * 2004-05-05 2005-11-09 ZLB Behring GmbH Therapeutic plasma protein-concentrates containing von willebrand factor as high molecular weight multimers
AU2014202595A1 (en) * 2007-12-28 2014-06-05 Baxalta GmbH Recombinant VWF Formulations
EP2244814B1 (en) * 2007-12-28 2021-06-02 Takeda Pharmaceutical Company Limited Recombinant vwf formulations
US11197916B2 (en) 2007-12-28 2021-12-14 Takeda Pharmaceutical Company Limited Lyophilized recombinant VWF formulations
NZ592704A (en) 2008-10-21 2013-02-22 Baxter Int Lyophilized recombinant von willebrand factor (rVWF) formulation comprising buffering agents, amino acids, stabilising agents and surfactants
SG191186A1 (en) 2010-12-15 2013-07-31 Baxter Int Eluate collection using conductivity gradient
MY187101A (en) 2012-06-15 2021-08-31 Commw Scient Ind Res Org Production of long chain polyunsaturated fatty acids in plant cells
ES2693380T3 (es) * 2013-11-08 2018-12-11 Csl Limited Nuevo método para concentrar el factor de von Willebrand o complejos de este
UA122768C2 (uk) 2013-12-18 2021-01-06 Коммонвелз Сайнтіфік Енд Індастріал Рисерч Организейшн Екстрагований рослинний ліпід, що містить довголанцюгові поліненасичені жирні кислоти
WO2015188224A1 (en) * 2014-06-13 2015-12-17 Csl Limited Improved production of recombinant von willebrand factor in a bioreactor
AU2015281791A1 (en) 2014-06-27 2017-01-12 Commonwealth Scientific And Industrial Research Organisation Lipid comprising docosapentaenoic acid
US10626164B2 (en) * 2014-07-25 2020-04-21 Csl Limited Purification of VWF
DE102020132156B4 (de) 2020-12-03 2022-11-03 Welbilt Deutschland GmbH Gargerät, insbesondere gewerbliches Gargerät

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5874265A (ja) 1981-10-29 1983-05-04 Honda Motor Co Ltd エンジンのシリンダヘツドの製造方法
JPS5874266A (ja) 1981-10-29 1983-05-04 Honda Motor Co Ltd エンジンのシリンダヘツドの製造方法
US5149787A (en) * 1984-05-22 1992-09-22 The Blood Center Research Foundation Method for maintaining intact, non-degraded factor VIII/von-Willebrand factor during blood processing
NL8500961A (nl) * 1985-04-01 1986-11-03 Stichting Vrienden Van De Stic Cdna-codering voor de humane von willebrand-factor, plasmiden met een dergelijke cdna-codering respektievelijk fragmenten ervan, alsmede micro-organismen, welke dergelijke plasmiden bevatten.
US5198349A (en) * 1986-01-03 1993-03-30 Genetics Institute, Inc. Method for producing factor VIII:C and analogs
US5200510A (en) * 1987-06-16 1993-04-06 Zymogenetics, Inc. Method for purifying factor viii:c, von willebrand factor and complexes thereof
US5006642A (en) * 1987-06-29 1991-04-09 Rhone-Poulenc Rorer Pharmaceuticals Inc. Purification of von Willebrand Factor by affinity chromatography
JPS6418261A (en) 1987-07-14 1989-01-23 Sanyo Electric Co Multigate-type metal insulator semiconductor device
DE3904354A1 (de) * 1989-02-14 1990-08-16 Behringwerke Ag Pasteurisiertes, gereinigtes von willebrand-faktor-konzentrat und verfahren zu seiner herstellung
FR2665449B1 (fr) * 1990-08-02 1995-04-14 Aquitaine Developp Transf Sang Procede de fabrication de facteur von willebrand ayant une tres haute purete, depourvu en majeure partie de facteur antihemophilique (fviiic), et facteur von willebrand ainsi obtenu, ainsi qu'une composition pharmaceutique le contenant.
US5198423A (en) * 1989-05-26 1993-03-30 Takara Shuzo Co., Ltd. Functional polypeptide containing a cell binding domain and a heparin binding domain of fibronectin
US5110907A (en) * 1989-08-01 1992-05-05 Alpha Therapeutic Corporation Factor viii complex purification using heparin affinity chromatography
JPH03210961A (ja) 1990-01-12 1991-09-13 Toyota Motor Corp シリンダヘッドの製造方法
FR2673632A1 (fr) * 1991-03-08 1992-09-11 Lille Transfusion Sanguine Procede de preparation de concentre de facteur von willebrand humain de tres haute purete, approprie a un usage therapeutique.
JP3270937B2 (ja) 1992-04-08 2002-04-02 ヤマハ発動機株式会社 エンジンのシリンダヘッド構造
JPH05332106A (ja) 1992-05-29 1993-12-14 Nissan Motor Co Ltd 内燃機関のバルブシート

Also Published As

Publication number Publication date
EP0705846A1 (de) 1996-04-10
ATE267841T1 (de) 2004-06-15
ES2221926T5 (es) 2009-04-16
EP0705846B2 (de) 2008-10-29
DK0705846T4 (da) 2009-01-19
DE59510905D1 (de) 2004-07-01
JP3110292B2 (ja) 2000-11-20
US5872099A (en) 1999-02-16
AT406866B (de) 2000-10-25
US5892005A (en) 1999-04-06
DE4435392B4 (de) 2008-02-07
EP0705846B1 (de) 2004-05-26
DE4435392A1 (de) 1996-04-11
US5869617A (en) 1999-02-09
ATA163595A (de) 2000-02-15
CA2159702C (en) 2010-03-09
CA2159702A1 (en) 1996-04-05
JPH08119997A (ja) 1996-05-14
ES2221926T3 (es) 2005-01-16

Similar Documents

Publication Publication Date Title
DK0705846T3 (da) Höjmolekylære og lavmolekylære fraktioner af von Willebrand-faktor
DK1616883T3 (da) Antistof imod VLA-4
DK0397633T3 (da) Fibronectinbindende protein samt fremstilling deraf
ATE370960T1 (de) Verknüpfte peptid-nukleinsäuren
DE3870957D1 (de) Werkstuecke aus superlegierung von hoher festigkeit mit gradierten eigenschaften.
NO179105C (no) Krystallinsk 2-0--D-glykopyranosyl-L-askorbinsyre og dets fremtilling og anvendelse
ATE193724T1 (de) Cd2 bindender bereich für das lymphocyten- funktion assoziierte antigen-3
DK564989D0 (da) Bindingsproteiner
ATE245442T1 (de) Getrocknete zubereitung von bluttfaktoren, enthaltend trehalose
DE3682455D1 (de) In stufen einstellbares mit pin-dioden geschaltetes hochfrequenz-daempfungsglied.
FI961083A (fi) Rekombinentti-IL4-vasta-aineita, jotka ovat käyttökelpoisia IL-4-välitteisten häiriötilojen hoidossa
EP0383234A3 (de) Pasteurisiertes, gereinigtes von Willebrand-Faktor-Konzentrat und Verfahren zu seiner Herstellung
IL82717A0 (en) Peptides that inhibit von willebrand factor binding
ES2103408T3 (es) Analogos de oligorribonucleotidos y ribozimas con uniones terminales en 3'-3' o 5'-5' respectivamente.
DK0754229T3 (da) Afamin: et humant serum albumin-lignende protein
PT90321A (pt) Processo para a preparacao de polipeptideos de veneno de vibora
DE3887861D1 (de) Vewendung von Aminen als Wärmestabilisierungsmittel in Organosiloxanzusammen-setzungen.
DK647389D0 (da) Annellerede indolo(3,2-c)-lactamer
ATE120494T1 (de) Fibronectinbindungsprotein und dessen herstellung.
DE69032665D1 (de) Polyamid-Zusammensetzungen mit verbesserter Anfärbbarkeit
DE3585494D1 (de) Zusammensetzungen von thermoplastischem polyester, enthaltend einige diepoxidharze mit niedrigem molekulargewicht, mit verbessertem schlagverhalten.
DE3683006D1 (de) Kautschukmodifizierte polyamidzusammensetzung.
DE69534738D1 (de) Leukocyten-aktivierender Faktor
DE3880651D1 (de) In der schmelze verarbeitbare aromatische polyesteramide mit 2,2'-substituierten biphenylenradikalen.
ZA882192B (en) Vascular anticoagulant proteins